Aryl hydrocarbon receptor-dependence of dioxin's effects on constitutive mouse hepatic cytochromes P450 and growth hormone signaling components

Canadian Journal of Physiology and Pharmacology

Volumn 90, Issue 10, 2012, Pages 1354-1363

  Lee, Chunja ^a   Riddick, David S ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

2,3,7,8 tetrachlorodibenzo p dioxin; Aryl hydrocarbon receptor; Cytochrome P450; Cytokine inducible Src homology 2 domain containing protein; Growth hormone receptor; Inflammatory markers; Janus kinase 2; Major urinary protein 2; NADPH cytochrome P450 oxidoreductase; Signal transducer and activator of transcription 5b

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 3 METHYLCHOLANTHRENE; AROMATIC HYDROCARBON RECEPTOR; CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 2D9; CYTOCHROME P450 3A11; CYTOCHROME P450 REDUCTASE; GROWTH HORMONE; GROWTH HORMONE RECEPTOR; JANUS KINASE 2; MESSENGER RNA; SERUM AMYLOID P; STAT5A PROTEIN; STAT5B PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION PROFILING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP3A; CYTOCHROME P-450 ENZYME SYSTEM; DOWN-REGULATION; ENVIRONMENTAL POLLUTANTS; ENZYME INDUCTION; JANUS KINASE 2; LIVER; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NADPH-FERRIHEMOPROTEIN REDUCTASE; PROTEINS; RECEPTORS, ARYL HYDROCARBON; RECEPTORS, SOMATOTROPIN; RNA, MESSENGER; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; TETRACHLORODIBENZODIOXIN;

EID: 84868117782     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/Y2012-099     Document Type: Article

References (56)

1. Ahluwalia, A., Clodfelter, K.H., and Waxman, D.J. 2004. Sexual dimorphism of rat liver gene expression: regulatory role of growth hormone revealed by deoxyribonucleic acid microarray analysis. Mol. Endocrinol. 18(3): 747-760. doi:10.1210/me.2003-0138. PMID:14684848.
2. Bhathena, A., Lee, C., and Riddick, D.S. 2002. Suppression of cytochrome P4502C11 by aromatic hydrocarbons: mechanistic insights from studies of the 5′-flanking region of the CYP2C11 gene. Drug Metab. Dispos. 30(12): 1385-1392. doi:10.1124/dmd. 30.12.1385. PMID:12433808.
3. Boutros, P.C., Yan, R., Moffat, I.D., Pohjanvirta, R., and Okey, A.B. 2008. Transcriptomic responses to 2,3,7,8-tetrachlorodibenzo-pdioxin (TCDD) in liver: comparison of rat and mouse. BMC Genomics, 9(1): 419. doi:10.1186/1471-2164-9-419. PMID: 18796159.
4. Boutros, P.C., Moffat, I.D., Okey, A.B., and Pohjanvirta, R. 2011a. mRNA levels in control rat liver display strain-specific, hereditary, and AHR-dependent components. PLoS ONE, 6(7): e18337. doi:10.1371/journal.pone.0018337. PMID:21760882.
5. Boutros, P.C., Yao, C.Q., Watson, J.D., Wu, A.H., Moffat, I.D., Prokopec, S.D., et al. 2011b. Hepatic transcriptomic responses to TCDD in dioxin-sensitive and dioxin-resistant rats during the onset of toxicity. Toxicol. Appl. Pharmacol. 251(2): 119-129. doi:10.1016/j.taap.2010.12.010. PMID:21215274.
6. Charles, K.A., Rivory, L.P., Brown, S.L., Liddle, C., Clarke, S.J., and Robertson, G.R. 2006. Transcriptional repression of hepatic cytochrome P450 3A4 gene in the presence of cancer. Clin. Cancer Res. 12(24): 7492-7497. doi:10.1158/1078-0432.CCR-06-0023. PMID:17189422.
7. Clodfelter, K.H., Holloway, M.G., Hodor, P., Park, S.H., Ray, W.J., and Waxman, D.J. 2006. Sex-dependent liver gene expression is extensive and largely dependent upon signal transducer and activator of transcription 5b (STAT5b): STAT5b-dependent activation of male genes and repression of female genes revealed by microarray analysis. Mol. Endocrinol. 20(6): 1333-1351. doi:10.1210/me.2005-0489. PMID:16469768.
8. Davey, H.W., Park, S.H., Grattan, D.R., McLachlan, M.J., and Waxman, D.J. 1999. STAT5b-deficient mice are growth hormone pulse-resistant: role of STAT5b in sex-specific liver P450 expression. J. Biol. Chem. 274(50): 35331-35336. doi:10.1074/jbc.274.50.35331. PMID:10585399.
9. Denison, M.S., and Nagy, S.R. 2003. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu. Rev. Pharmacol. Toxicol. 43(1): 309-334. doi:10.1146/annurev.pharmtox.43.100901.135828. PMID:12540743.
10. Fernandez-Salguero, P.M., Hilbert, D.M., Rudikoff, S., Ward, J.M., and Gonzalez, F.J. 1996. Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity. Toxicol. Appl. Pharmacol. 140(1): 173-179. doi:10.1006/taap.1996.0210. PMID:8806883.
11. Hollingshead, B.D., Beischlag, T.V., Dinatale, B.C., Ramadoss, P., and Perdew, G.H. 2008. Inflammatory signaling and aryl hydrocarbon receptor mediate synergistic induction of interleukin 6 in MCF-7 cells. Cancer Res. 68(10): 3609-3617. doi:10.1158/0008-5472.CAN-07-6168. PMID:18483242.
12. Ito, S., Chen, C., Satoh, J., Yim, S.H., and Gonzalez, F.J. 2007. Dietary phytochemicals regulate wholebody CYP1A1 expression through an arylhydrocarbon receptor nuclear translocator-dependent system in gut. J. Clin. Invest. 117(7): 1940-1950. doi:10.1172/JCI31647. PMID:17607366.
13. Jarukamjorn, K., Sakuma, T., Jaruchotikamol, A., Ishino, Y., Oguro, M., and Nemoto, N. 2006. Modified expression of cytochrome P450 mRNAs by growth hormone in mouse liver. Toxicology, 219 (1-3): 97-105. doi:10.1016/j.tox.2005.11.014. PMID:16377053.
14. Jones, E.J., and Riddick, D.S. 1996. Regulation of constitutive rat hepatic cytochromes P450 by 3-methylcholanthrene. Xenobiotica, 26(10): 995-1012. doi:10.3109/00498259609167418. PMID: 8905915.
15. Kondraganti, S.R., Muthiah, K., Jiang, W.W., Barrios, R., and Moorthy, B. 2005. Effects of 3-methylcholanthrene on gene expression profiling in the rat using cDNA microarray analyses. Chem. Res. Toxicol. 18(11): 1634-1641. doi:10.1021/tx050085n. PMID:16300371.
16. Lahvis, G.P., Lindell, S.L., Thomas, R.S., McCuskey, R.S., Murphy, C., Glover, E., et al. 2000. Portosystemic shunting and persistent fetal vascular structures in aryl hydrocarbon receptor-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 97(19): 10442-10447. doi:10.1073/pnas.190256997. PMID:10973493.
17. Landsman, T., and Waxman, D.J. 2005. Role of the cytokine-induced SH2 domain-containing protein CIS in growth hormone receptor internalization. J. Biol. Chem. 280(45): 37471-37480. doi:10.1074/jbc.M504125200. PMID:16154995.
18. Lee, C., and Riddick, D.S. 2000. Transcriptional suppression of cytochrome P4502C11 gene expression by 3-methylcholanthrene. Biochem. Pharmacol. 59(11): 1417-1423. doi:10.1016/S0006-2952(00)00249-5. PMID:10751551.
19. Lee, C., Hutson, J.R., Tzau, V.K.-F., and Riddick, D.S. 2006. Regulation of constitutive mouse hepatic cytochromes P450 and growth hormone signaling components by 3-methylcholanthrene. Drug Metab. Dispos. 34(9): 1530-1538. doi:10.1124/dmd.106.009936. PMID:16782765.
20. Li, W., Vogel, C.F., Wu, D., and Matsumura, F. 2010. Non-genomic action of TCDD to induce inflammatory responses in HepG2 human hepatoma cells and in liver of C57BL/6J mice. Biol. Chem. 391(10): 1205-1219. doi:10.1515/bc.2010.126. PMID:20707612.
21. Mathieu, M.C., Lapierre, I., Brault, K., and Raymond, M. 2001. Aromatic hydrocarbon receptor (AhR)·AhR nuclear translocatorand p53-mediated induction of the murine multidrug resistance Mdr1 gene by 3-methylcholanthrene and benzo[a]pyrene in hepatoma cells. J. Biol. Chem. 276(7): 4819-4827. doi:10.1074/jbc.M008495200. PMID:11096091.
22. Moffat, I.D., Boutros, P.C., Chen, H., Okey, A.B., and Pohjanvirta, R. 2010. Aryl hydrocarbon receptor (AHR)-regulated transcriptomic changes in rats sensitive or resistant to major dioxin toxicities. BMC Genomics, 11(1): 263. doi:10.1186/1471-2164-11-263. PMID:20420666.
23. Morgan, E.T., Goralski, K.B., Piquette-Miller, M., Renton, K.W., Robertson, G.R., Chaluvadi, M.R., et al. 2008. Regulation of drugmetabolizing enzymes and transporters in infection, inflammation, and cancer. Drug Metab. Dispos. 36(2): 205-216. doi:10.1124/ dmd.107.018747. PMID:18218849.
24. Muguruma, M., Nishimura, J., Jin, M., Kashida, Y., Moto, M., Takahashi, M., et al. 2006. Molecular pathological analysis for determining the possible mechanism of piperonyl butoxideinduced hepatocarcinogenesis in mice. Toxicology, 228(2-3): 178-187. doi:10.1016/j.tox.2006.08.029. PMID:17014948.
25. Nguyen, L.P., and Bradfield, C.A. 2008. The search for endogenous activators of the aryl hydrocarbon receptor. Chem. Res. Toxicol. 21(1): 102-116. doi:10.1021/tx7001965. PMID:18076143.
26. Nukaya, M., Takahashi, Y., Gonzalez, F.J., and Kamataki, T. 2004. Aryl hydrocarbon receptor-mediated suppression of GH receptor and Janus kinase 2 expression in mice. FEBS Lett. 558(1-3): 96-100. doi:10.1016/S0014-5793(03)01528-X. PMID:14759523.
27. Pansoy, A., Ahmed, S., Valen, E., Sandelin, A., and Matthews, J. 2010. 3-Methylcholanthrene induces differential recruitment of aryl hydrocarbon receptor to human promoters. Toxicol. Sci. 117 (1): 90-100. doi:10.1093/toxsci/kfq096. PMID:20348232.
28. Park, S.H., and Waxman, D.J. 2001. Inhibitory cross-talk between STAT5b and liver nuclear factor HNF3b: impact on the regulation of growth hormone pulse-stimulated, male-specific liver cytochrome P-450 gene expression. J. Biol. Chem. 276(46): 43031-43039. doi:10.1074/jbc.M107597200. PMID:11562369.
29. Patel, R.D., Murray, I.A., Flaveny, C.A., Kusnadi, A., and Perdew, G.H. 2009. Ah receptor represses acute-phase response gene expression without binding to its cognate response element. Lab. Invest. 89(6): 695-707. doi:10.1038/labinvest.2009.24. PMID: 19333233.
30. Pohjanvirta, R., and Tuomisto, J. 1994. Short-term toxicity of 2,3,7,8- tetrachlorodibenzo-p-dioxin in laboratory animals: effects, mechanisms, and animal models. Pharmacol. Rev. 46(4): 483-549. PMID:7899475.
31. Poland, A., and Glover, E. 1974. Comparison of 2,3,7,8-tetrachlorodibenzo- p-dioxin, a potent inducer of aryl hydrocarbon hydroxylase, with 3-methylcholanthrene. Mol. Pharmacol. 10(2): 349-359. PMID:4851117.
32. Poland, A., and Knutson, J.C. 1982. 2,3,7,8-Tetrachlorodibenzo-pdioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Annu. Rev. Pharmacol. Toxicol. 22(1): 517-554. doi:10.1146/annurev.pa.22.040182.002505. PMID:6282188.
33. Reddy, G.R., Pushpanathan, M.J., Ransom, R.F., Holzman, L.B., Brosius, F.C., 3rd, Diakonova, M., et al. 2007. Identification of the glomerular podocyte as a target for growth hormone action. Endocrinology, 148(5): 2045-2055. doi:10.1210/en.2006-1285. PMID:17272398.
34. Riddick, D.S., Huang, Y., Harper, P.A., and Okey, A.B. 1994. 2,3,7,8-Tetrachlorodibenzo-p-dioxin versus 3-methylcholanthrene: comparative studies of Ah receptor binding, transformation, and induction of Cyp1a1. J. Biol. Chem. 269(16): 12118-12128. PMID:8163516.
35. Riddick, D.S., Lee, C., Bhathena, A., and Timsit, Y.E. 2003. The 2001 Veylien Henderson Award of the Society of Toxicology of Canada. Positive and negative transcriptional regulation of cytochromes P450 by polycyclic aromatic hydrocarbons. Can. J. Physiol. Pharmacol. 81(1): 59-77. doi:10.1139/y03-003. PMID: 12665258.
36. Riddick, D.S., Lee, C., Bhathena, A., Timsit, Y.E., Cheng, P.Y., Morgan, E.T., et al. 2004. Transcriptional suppression of cytochrome P450 genes by endogenous and exogenous chemicals. Drug Metab. Dispos. 32(4): 367-375. doi:10.1124/dmd.32.4.367. PMID:15039287.
37. Safa, B., Lee, C., and Riddick, D.S. 1997. Role of the aromatic hydrocarbon receptor in the suppression of cytochrome P-450 2C11 by polycyclic aromatic hydrocarbons. Toxicol. Lett. 90(2-3): 163-175. doi:10.1016/S0378-4274(96)03843-X. PMID:9067484.
38. Sakuma, T., Endo, Y., Mashino, M., Kuroiwa, M., Ohara, A., Jarukamjorn, K., and Nemoto, N. 2002. Regulation of the expression of two female-predominant CYP3A mRNAs (CYP3A41 and CYP3A44) in mouse liver by sex and growth hormones. Arch. Biochem. Biophys. 404(2): 234-242. doi:10.1016/S0003-9861(02)00329-6. PMID:12147261.
39. Sawaya, R.M., and Riddick, D.S. 2008a. Cytochrome P450 2C11 5′- flanking region and promoter: regulation by aromatic hydrocarbons in vitro. Toxicology, 248(2-3): 104-112. doi:10.1016/j.tox.2008.03.011. PMID:18440119.
40. Sawaya, R.M., and Riddick, D.S. 2008b. Cytochrome P450 2C11 5′- flanking region and promoter mediate in vivo suppression by 3- methylcholanthrene. Drug Metab. Dispos. 36(9): 1803-1811. doi:10.1124/dmd.108.020966. PMID:18524872.
41. Schmidt, J.V., and Bradfield, C.A. 1996. Ah receptor signaling pathways. Annu. Rev. Cell Dev. Biol. 12(1): 55-89. doi:10.1146/ annurev.cellbio.12.1.55. PMID:8970722.
42. Schmidt, J.V., Su, G.H.T., Reddy, J.K., Simon, M.C., and Bradfield, C.A. 1996. Characterization of a murine Ahr null allele: involvement of the Ah receptor in hepatic growth and development. Proc. Natl. Acad. Sci. U.S.A. 93(13): 6731-6736. doi:10.1073/pnas.93.13.6731. PMID:8692887.
43. Shimada, T., Inoue, K., Suzuki, Y., Kawai, T., Azuma, E., Nakajima, T., et al. 2002. Arylhydrocarbon receptor-dependent induction of liver and lung cytochromes P450 1A1, 1A2, and 1B1 by polycyclic aromatic hydrocarbons and polychlorinated biphenyls in genetically engineered C57BL/6J mice. Carcinogenesis, 23(7): 1199-1207. doi:10.1093/carcin/23.7.1199. PMID:12117779.
44. Shimizu, Y., Nakatsuru, Y., Ichinose, M., Takahashi, Y., Kume, H., Mimura, J., et al. 2000. Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor. Proc. Natl. Acad. Sci. U.S.A. 97(2): 779-782. doi:10.1073/pnas.97.2.779. PMID: 10639156.
45. Smith, A.G., Davies, R., Dalton, T.P., Miller, M.L., Judah, D., Riley, J., et al. 2003. Intrinsic hepatic phenotype associated with the Cyp1a2 gene as shown by cDNA expression microarray analysis of the knockout mouse. EHP Toxicogenomics, 111(1T): 45-51. PMID:12735109.
46. Stockinger, B., Hirota, K., Duarte, J., and Veldhoen, M. 2011. External influences on the immune system via activation of the aryl hydrocarbon receptor. Semin. Immunol. 23(2): 99-105. doi:10.1016/j.smim.2011.01.008. PMID:21288737.
47. Tijet, N., Boutros, P.C., Moffat, I.D., Okey, A.B., Tuomisto, J., and Pohjanvirta, R. 2006. Aryl hydrocarbon receptor regulates distinct dioxin-dependent and dioxin-independent gene batteries. Mol. Pharmacol. 69(1): 140-153. PMID:16214954.
48. Timsit, Y.E., and Riddick, D.S. 2000. Interference with growth hormone stimulation of hepatic cytochrome P4502C11 expression in hypophysectomized male rats by 3-methylcholanthrene. Toxicol. Appl. Pharmacol. 163(2): 105-114. doi:10.1006/taap.1999. 8862. PMID:10698668.
49. Timsit, Y.E., and Riddick, D.S. 2002. Stimulation of hepatic signal transducer and activator of transcription 5b by GH is not altered by 3-methylcholanthrene. Endocrinology, 143(9): 3284-3294. doi:10.1210/en.2002-220212. PMID:12193540.
50. Udy, G.B., Towers, R.P., Snell, R.G., Wilkins, R.J., Park, S.H., Ram, P.A., et al. 1997. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc. Natl. Acad. Sci. U.S.A. 94(14): 7239-7244. doi:10.1073/pnas.94.14.7239. PMID:9207075.
51. Whitlock, J.P., Jr. 1999. Induction of cytochrome P4501A1. Annu. Rev. Pharmacol. Toxicol. 39(1): 103-125. doi:10.1146/annurev. pharmtox.39.1.103. PMID:10331078.
52. Wiwi, C.A., Gupte, M., and Waxman, D.J. 2004. Sexually dimorphic P450 gene expression in liver-specific hepatocyte nuclear factor 4a-deficient mice. Mol. Endocrinol. 18(8): 1975-1987. doi:10.1210/me.2004-0129. PMID:15155787.
53. Yanagiba, Y., Ito, Y., Kamijima, M., Gonzalez, F.J., and Nakajima, T. 2009. Octachlorostyrene induces cytochrome P450, UDP-glucuronosyltransferase, and sulfotransferase via the aryl hydrocarbon receptor and constitutive androstane receptor. Toxicol. Sci. 111(1): 19-26. doi:10.1093/toxsci/kfp130. PMID:19525444.
54. Yanagimoto, T., Itoh, S., Sawada, M., and Kamataki, T. 1997. Mouse cytochrome P450 (Cyp3a11): predominant expression in liver and capacity to activate aflatoxin B1. Arch. Biochem. Biophys. 340(2): 215-218. doi:10.1006/abbi.1997.9900. PMID:9143324.
55. Yang, X.P., Schaper, F., Teubner, A., Lammert, F., Heinrich, P.C., Matern, S., and Siewert, E. 2005. Interleukin-6 plays a crucial role in the hepatic expression of SOCS3 during acute inflammatory processes in vivo. J. Hepatol. 43(4): 704-710. doi:10.1016/j.jhep. 2005.02.048. PMID:16040151.
56. Yao, C.Q., Prokopec, S.D., Watson, J.D., Pang, R., P'ng, C., Chong, L.C., et al. 2012. Inter-strain heterogeneity in rat hepatic transcriptomic responses to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol. Appl. Pharmacol. 260(2): 135-145. doi:10. 1016/j.taap.2012.02.001. PMID:22342509.